Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Long-term freedom from insulin may be achieved with duodenal electroporation plus semaglutide
The combination of re-cellularization via electroporation therapy (ReCET) plus semaglutide appears to improve glucose control and metabolic health and eliminate the need for insulin therapy in most patients with type 2 diabetes (T2D), with the effects maintained up to 2 years, according to the follow-up data from the single-arm, dose-finding, first-in-human EMINENT trial.
Long-term freedom from insulin may be achieved with duodenal electroporation plus semaglutide
23 Sep 2024
Ultra-low dose EBRT feasible in primary cutaneous B-cell lymphoma
Patients with primary cutaneous B-cell lymphoma (PCBCL) treated with ultra-low dose external beam radiation therapy (EBRT) to 4 Gy total dose in two fractions experience durable local control without skin toxicity, reports a study.
Ultra-low dose EBRT feasible in primary cutaneous B-cell lymphoma
23 Sep 2024
What fuels flu, pneumococcal vaccine hesitancy in SG?
In Singapore, influenza and pneumococcal vaccination coverage remains stubbornly low. Results of two separate analysis of a cross-sectional survey shed light on this concerning trend, highlighting the roles of vaccine knowledge and attitude, healthcare professionals, and social support in influencing vaccination decisions.
What fuels flu, pneumococcal vaccine hesitancy in SG?
23 Sep 2024
Botanical compound boosts blood sugar control in prediabetes, early T2D
The novel plant-based polyphenol-rich compound, TOTUM-63, helps keep the lid on fasting plasma glucose (FPG) and other measures of glucose dysregulation in people with prediabetes and early type 2 diabetes (T2D), according to the pivotal phase II/III REVERSE-IT study.